The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers ...Middle East

PR Newswire - News
The Alzheimers Drug Discovery Foundations Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers

New investment helps to ensure patients can access high-quality and reproducible testing across labs worldwide NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Invests in Expansion of Quality Control Program for Blood and CSF Biomarkers )

    Also on site :



    Latest News